KYVERNA THERAPEUTICS INC (KYTX) Institutional Shareholders
KYVERNA THERAPEUTICS INC (KYTX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $326.45M in KYTX holdings during the latest filing period.
Gordonmd Global Investments Lp is currently the largest disclosed institutional shareholder of KYTX tracked by InsiderSet, reporting ownership valued at approximately $37.82M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $36.08M, representing an estimated loss of -4.60% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 66% of the total disclosed KYTX value among the investors covered in this analysis. Major shareholders include Gordonmd Global Investments Lp, Gilead Sciences, Inc., Blackrock, Inc., and several other long-term asset managers with concentrated positions in KYVERNA THERAPEUTICS INC (KYTX).
This page ranks the largest institutional KYTX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
120
Total Reported Value
$326.45M
Largest Holder
Gordonmd Global Investments Lp
Largest Position
$37.82M
Insider Transactions (90d)
5
Latest Filing Quarter
Q2 2026
New Institutional Positions
154
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Gordonmd Global Investments Lp | 18.30% | 4,244,818 | $37,821,328 | $36,080,953 | -$1,740,375 | -4.60% | |
| Gilead Sciences, Inc. | 2.23% | 4,126,119 | $36,763,720 | $35,072,012 | -$1,691,709 | -4.60% | |
| Blackrock, Inc. | 0.00% | 3,134,807 | $27,931,130 | $26,645,860 | -$1,285,271 | -4.60% | |
| Bain Capital Life Sciences Investors, Llc | 1.53% | 2,885,000 | $25,705,350 | $24,522,500 | -$1,182,850 | -4.60% | |
| Aigh Capital Management Llc | 2.26% | 2,795,797 | $24,910,552 | $23,764,275 | -$1,146,278 | -4.60% | |
| Deerfield Management Company, L.P. | 0.19% | 2,000,000 | $17,820,000 | $17,000,000 | -$820,000 | -4.60% | |
| Vanguard Capital Management Llc | 0.00% | 1,897,451 | $16,906,288 | $16,128,334 | -$777,955 | -4.60% | |
| Geode Capital Management, Llc | 0.00% | 1,049,430 | $9,352,537 | $8,920,155 | -$432,382 | -4.62% | |
| Insight Holdings Group, Llc | 0.67% | 989,054 | $8,812,471 | $8,406,959 | -$405,512 | -4.60% | |
| Morgan Stanley | 0.00% | 982,307 | $8,752,355 | $8,349,610 | -$402,746 | -4.60% | |
| State Street Corp | 0.00% | 982,233 | $8,751,696 | $8,348,981 | -$402,716 | -4.60% | |
| Propel Bio Management, Llc | 4.12% | 883,198 | $7,869,294 | $7,507,183 | -$362,111 | -4.60% | |
| Woodline Partners Lp | 0.02% | 845,325 | $7,531,846 | $7,185,263 | -$346,584 | -4.60% | |
| Millennium Management Llc | 0.00% | 639,780 | $5,700,440 | $5,438,130 | -$262,310 | -4.60% | |
| Mbb Public Markets I Llc | 0.59% | 614,477 | $5,474,990 | $5,223,055 | -$251,936 | -4.60% | |
| Adage Capital Partners Gp, L.L.C. | 0.01% | 500,000 | $4,455,000 | $4,250,000 | -$205,000 | -4.60% | |
| D. E. Shaw & Co., Inc. | 0.00% | 469,346 | $4,181,872 | $3,989,441 | -$192,431 | -4.60% | |
| Wells Fargo & Company/Mn | 0.00% | 373,009 | $3,323,510 | $3,170,577 | -$152,934 | -4.60% | |
| Ubs Group Ag | 0.00% | 365,574 | $3,257,264 | $3,107,379 | -$149,885 | -4.60% | |
| Goldman Sachs Group Inc | 0.00% | 335,230 | $2,986,899 | $2,849,455 | -$137,444 | -4.60% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 333,899 | $2,975,040 | $2,838,142 | -$136,899 | -4.60% |
| Charles Schwab Investment Management Inc | 0.00% | 319,666 | $2,848,224 | $2,717,161 | -$131,063 | -4.60% | |
| Sixth Street Partners Management Company, L.P. | 0.00% | 319,666 | $2,848,224 | $2,717,161 | -$131,063 | -4.60% | |
| Northern Trust Corp | 0.00% | 315,354 | $2,809,805 | $2,680,509 | -$129,296 | -4.60% | |
| Bnp Paribas Financial Markets | 0.00% | 310,632 | $2,767,731 | $2,640,372 | -$127,359 | -4.60% | |
| Vanguard Portfolio Management Llc | 0.00% | 282,189 | $2,514,304 | $2,398,607 | -$115,698 | -4.60% | |
| Bank Of America Corp | 0.00% | 265,405 | $2,364,759 | $2,255,943 | -$108,817 | -4.60% | |
| Vanguard Fiduciary Trust Co | 0.00% | 259,667 | $2,313,633 | $2,207,170 | -$106,464 | -4.60% | |
| Walleye Capital Llc | 0.01% | 245,587 | $2,188,180 | $2,087,490 | -$100,691 | -4.60% | |
| Y-Intercept (Hong Kong) Ltd | 0.04% | 242,387 | $2,159,668 | $2,060,290 | -$99,379 | -4.60% | |
| Nuveen, Llc | 0.00% | 233,743 | $2,082,650 | $1,986,816 | -$95,835 | -4.60% | |
| Burkehill Global Management, Lp | 0.06% | 200,000 | $1,782,000 | $1,700,000 | -$82,000 | -4.60% | |
| Simplify Asset Management Inc. | 0.02% | 182,603 | $1,626,993 | $1,552,126 | -$74,868 | -4.60% | |
| Susquehanna International Group, Llp | 0.00% | 155,800 | $1,388,178 | $1,324,300 | -$63,878 | -4.60% | |
| Bridgeway Capital Management, Llc | 0.02% | 149,900 | $1,335,609 | $1,274,150 | -$61,459 | -4.60% | |
| Citadel Advisors Llc | 0.00% | 147,627 | $1,315,357 | $1,254,830 | -$60,528 | -4.60% | |
| Td Asset Management Inc | 0.00% | 145,682 | $1,298,027 | $1,238,297 | -$59,730 | -4.60% | |
| Stifel Financial Corp | 0.00% | 139,965 | $1,247,088 | $1,189,703 | -$57,386 | -4.60% | |
| Qube Research & Technologies Ltd | 0.00% | 123,646 | $1,101,686 | $1,050,991 | -$50,695 | -4.60% | |
| Barclays Plc | 0.00% | 117,844 | $1,049,991 | $1,001,674 | -$48,317 | -4.60% | |
| Wellington Management Group Llp | 0.00% | 117,442 | $1,046,409 | $998,257 | -$48,152 | -4.60% | |
| Wesbanco Bank Inc | 0.02% | 110,300 | $982,773 | $937,550 | -$45,223 | -4.60% | |
| Jump Financial, Llc | 0.01% | 101,352 | $903,046 | $861,492 | -$41,554 | -4.60% | |
| Bank Of New York Mellon Corp | 0.00% | 100,281 | $893,504 | $852,389 | -$41,116 | -4.60% | |
| Fmr Llc | 0.00% | 96,051 | $855,813 | $816,434 | -$39,380 | -4.60% | |
| Balyasny Asset Management L.P. | 0.00% | 96,048 | $855,788 | $816,408 | -$39,380 | -4.60% | |
| Susquehanna Portfolio Strategies, Llc | 0.01% | 88,845 | $791,609 | $755,183 | -$36,427 | -4.60% | |
| Squarepoint Ops Llc | 0.00% | 82,867 | $738,345 | $704,370 | -$33,976 | -4.60% | |
| Manufacturers Life Insurance Company, The | 0.00% | 82,207 | $732,464 | $698,760 | -$33,705 | -4.60% | |
| Dimensional Fund Advisors Lp | 0.00% | 78,419 | $698,713 | $666,562 | -$32,152 | -4.60% |
Frequently asked questions about KYTX
Who owns the most KYTX stock?
The largest holders of KYTX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for KYVERNA THERAPEUTICS INC (KYTX).
Is KYTX widely held by superinvestors?
Many widely followed stocks like KYTX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly KYTX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.